KD Logo

Goldman upgrades Ultragenyx Pharmaceutical Inc (RARE) stock to a Buy

In a filing, Ultragenyx Pharmaceutical Inc revealed its President & CEO KAKKIS EMIL D unloaded Company’s shares for reported $0.5 million on Dec 30 ’24. In the deal valued at $42.23 per share,11,727 shares were sold. As a result of this transaction, KAKKIS EMIL D now holds 2,183,985 shares worth roughly $93.02 million.

Then, KAKKIS EMIL D bought 11,727 shares, generating $495,264 in total proceeds.

Before that, KAKKIS EMIL D sold 8,273 shares. Ultragenyx Pharmaceutical Inc shares valued at $413,650 were divested by the President & CEO at a price of $50.00 per share. As a result of the transaction, KAKKIS EMIL D now holds 2,195,712 shares, worth roughly $93.52 million.

Goldman upgraded its Ultragenyx Pharmaceutical Inc [RARE] rating to a Buy from a a Neutral in a research note published on June 06, 2024; the price target was increased to $67 from $56. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late April with a ‘”an Outperform”‘ rating. Wells Fargo began covering RARE with “an Overweight” recommendation on December 08, 2023.

Price Performance Review of RARE

On Friday, Ultragenyx Pharmaceutical Inc [NASDAQ:RARE] saw its stock fall -4.25% to $42.59. Over the last five days, the stock has lost -2.14%. Ultragenyx Pharmaceutical Inc shares have risen nearly 1.24% since the year began. Nevertheless, the stocks have fallen -11.03% over the past one year. While a 52-week high of $60.37 was reached on 02/06/25, a 52-week low of $37.02 was recorded on 01/14/25. SMA at 50 days reached $43.71, while 200 days put it at $47.25.

Levels Of Support And Resistance For RARE Stock

The 24-hour chart illustrates a support level at 41.75, which if violated will result in even more drops to 40.92. On the upside, there is a resistance level at 44.21. A further resistance level may holdings at 45.84. The Relative Strength Index (RSI) on the 14-day chart is 44.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.28, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.97%. Stochastics %K at 43.12% indicates the stock is a holding.

Most Popular